Income Taxes
12 Months Ended
Nov. 30, 2021
Income Taxes  
Income Taxes

15. Income taxes

 

The Company files Canadian income tax returns for its Canadian operations. Separate income tax returns are filed as locally required.

The total provision for income taxes differs from the amount which would be computed by applying the Canadian income tax rate to loss before income taxes. The reasons for these differences are as follows:

 

 

 

November 30,

 

 

 November 30,

 

 

 November 30,

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

%

 

 

%

 

 

%

 

Statutory income tax rate

 

 

26.5

 

 

 

26.5

 

 

 

26.5

 

 

 

$

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Statutory income tax recovery

 

 

(1,393,726)

 

 

(889,905)

 

 

(2,143,853)

Increase (decrease) in income taxes

 

 

 

 

 

 

 

 

 

 

 

 

Non-deductible expenses/non-taxable income

 

 

53,470

 

 

 

47,287

 

 

 

79,210

 

Change in valuation allowance

 

 

540,925

 

 

 

843,877

 

 

 

2,425,721

 

Investment tax credit

 

 

-

 

 

 

-

 

 

 

(364,955)

Financing costs booked to equity

 

 

(10,128)

 

 

-

 

 

 

-

 

Difference in foreign tax rates

 

 

(98)

 

 

-

 

 

 

(1,487)

True up of tax returns

 

 

-

 

 

 

-

 

 

 

-

 

Tax loss expired and other

 

 

695,370

 

 

 

(9,069)

 

 

-

 

Global intangible low-taxed income (GILTI)

 

 

 

 

 

 

40,643

 

 

 

-

 

Income tax expense (recovery)

 

 

(114,187)

 

 

32,833

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The Company's income tax expense (recovery) is allocated as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current tax expense

 

 

(20,333)

 

 

32,833

 

 

 

5,678

 

Deferred tax recovery

 

 

(93,854)

 

 

-

 

 

 

(11,042)

 

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities and certain carry-forward balances.Significant temporary differences and carry-forwards are as follows:

 

 

 

2021

 

 

2020

 

 

 

$

 

 

$

 

Deferred tax assets

 

 

 

 

 

 

Non-capital loss carry-forwards

 

 

16,323,553

 

 

 

14,690,358

 

Book and tax basis differences on assets and liabilities

 

 

1,527,791

 

 

 

1,274,734

 

Other

 

 

1,509,122

 

 

 

1,263,175

 

Investment tax credit

 

 

2,850,496

 

 

 

3,405,090

 

Undeducted research and development expenditures

 

 

4,227,211

 

 

 

4,990,176

 

Capital loss carryforwards

 

 

318,915

 

 

 

318,915

 

Share issuance cost

 

 

227,253

 

 

 

492,243

 

 

 

 

26,984,341

 

 

 

26,434,691

 

Deferred tax liabilities

 

 

 

 

 

 

 

 

Unrealized foreign exchange gain

 

 

(271,913)

 

 

(271,913)

Convertible debentures

 

 

(12,857)

 

 

(4,132)

 

 

 

(284,770)

 

 

(276,045)

 

 

 

 

 

 

 

 

 

Valuation allowances for deferred tax assets

 

 

(26,699,571

)

 

 

(26,158,646)

Net deferred tax assets

 

 

-

 

 

 

-

 

 

Deferred tax assets and liabilities have been offset where they relate to income taxes levied by the same taxation authority and the Company has the legal right and intent to offset.

 

Movement in net deferred tax assets (liabilities):

 

 

 

2021

 

 

2020

 

 

 

$

 

 

$

 

Balance at the beginning of the year

 

 

-

 

 

 

-

 

Recognized in profit/loss

 

 

(93,854)

 

 

-

 

Recognized in shareholders' equity

 

 

93,854

 

 

 

-

 

Balance at the end of the year

 

 

-

 

 

 

-

 

At November 30, 2021, the Company had cumulative operating losses available to reduce future years’ income for income tax purposes:

 

Canadian income tax losses expiring in the year ended November 30,

 

Federal

 

 

 

$

 

2029

 

 

609,497

 

2030

 

 

3,717,403

 

2031

 

 

6,154,180

 

2032

 

 

6,410,970

 

2033

 

 

4,984,768

 

2034

 

 

149,927

 

2035

 

 

2,634,823

 

2036

 

 

3,404,504

 

2037

 

 

4,328,444

 

2038

 

 

11,231,494

 

2039

 

 

9,891,661

 

2040

 

 

3,111,826

 

2041

 

 

4,968,817

 

 

 

 

61,598,314

 

 

The Company has had no taxable income under the Federal and Provincial tax laws of Canada for the year ended November 30, 2021. The Company has non-capital loss carry-forwards at November 30, 2021, totaling $61,598,314 in Canada that must be offset against future taxable income. If not utilized, the loss carry-forwards will expire between 2029 and 2041.

 

At November 30, 2021, the Company had a cumulative carry-forward pool of Canadian Federal Scientific Research & Experimental Development expenditures in the amount of $15,951,739 (2020 - $18,830,851) which can be carried forward indefinitely.

 

At November 30, 2021, the Company had approximately $2,933,013 (2020 - $3,508,087) of unclaimed Investment Tax Credits which expire from 2025 to 2039. These credits are subject to a full valuation allowance as they are not more likely than not to be realized.

 

The net deferred tax assets have been fully offset by a valuation allowance because it is not more likely than not the Company will realize the benefit of these deferred tax assets. The Company does not have any recognized tax benefits as of November 30, 2021 or November 30, 2020.

 

The Company files unconsolidated federal income tax returns domestically and in foreign jurisdictions. The Company has open tax years from 2009 to 2020 with tax jurisdictions including Canada and the U.S. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and regulations, as they relate to amount, timing, or inclusion of revenues and expenses.

 

The Company had no accrued interest and penalties as of November 30, 2021, 2020 and 2019.